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Analysis of Proteins with Caseinolytic Activity in a Human
Stratum Corneum Extract Revealed aYet Unidenti¢ed Cysteine
Protease and Identi¢ed the So-Called ‘‘Stratum Corneum
Thiol Protease’’ as Cathepsin L2
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Desquamation is described as a protease-dependent
phenomenon where serine proteases with a basic pH
optimum play a key role. Recently proteases with an
acidic pH optimum were identi¢ed in the stratum-
corneum and associated with desquamation, e.g., cathe-
psin D and the stratum corneum thiol protease. The
purpose of this study was to investigate if human stra-
tum corneum contains proteases di¡erent from the
above, exhibiting similar properties. After gel ¢ltration,
we identi¢ed four distinct proteolytic activities in a hu-
man stratum corneum extract, a cathepsin-E-like activ-
ity (80 kDa), a cathepsin-D activity (40 kDa), a yet
unknown cathepsin-L-like form (28 kDa) exhibiting
the highest caseinolytic activity, and a chymotrypsin-
like protein (24 kDa) containing the acidic activity of
the well described stratum corneum chymotryptic en-
zyme. We named the new 28 kDa protease stratum
corneum cathepsin-L-like enzyme. Characterization of
stratum corneum cathepsin-L-like enzyme provided
clear evidence that this new protease, despite its mem-
bership to the cathepsin-L-like family, is distinct from
cathepsin L and from the recently described stratum
corneum thiol protease. Its ability to hydrolyze corneo-
desmosin, a marker of corneocyte cohesion, was in
favor of a role of stratum corneum cathepsin-L-like en-
zyme in the desquamation process. A more detailed
analysis did not allow us to identify stratum corneum
cathepsin-L-like enzyme at the molecular level but re-
vealed that stratum corneum thiol protease is identical
with the recently described cathepsin L2 protease. Re-
verse transcription polymerase chain reaction studies
and the use of a speci¢c antibody revealed that, in con-
trast to earlier reports, expression of stratum corneum
thiol protease in human epidermis is not related to ker-
atinocyte di¡erentiation. Our results indicate that the
stratum corneum thiol protease is probably expressed
as a pro-enzyme in the lower layers of the epidermis
and in part activated by a yet unidenti¢ed mechanism
in the upper layers during keratinocyte di¡erentiation.
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A
balance between cell shedding at the skin surface
and keratinocyte proliferation in the basal layer of
the epidermis is necessary for the maintenance of a
functional normal stratum corneum (SC) assuring
an e⁄cient physiochemical barrier for our organism
against a hostile environment. The desquamation process is a pre-
cisely controlled cascade of events, the molecular mechanisms of
which are only known in part and have to be put correctly in
place to resolve the puzzle. It is now generally accepted that SC
cohesion is essentially mediated through desmosome derived
structures, called corneosomes or corneodesmosomes (Serre et al,
1991; Walsh and Chapman, 1991). The entry of corneocytes into
the stratum disjunctum is characterized by a dramatic loss of non-
peripheral corneodesmosomes, resulting in an intercorneocyte
adhesion restricted to the overlapping edges. The selective
degradation of the nonperipheral corneodesmosomes and the
preservation of the edge structures might indicate that, at this
stage, the lateral structures are protected against proteolysis, pos-
sibly by distinct carbohydrate entities (Walsh and Chapman, 1991).
The key event that eventually results in desquamation (cell
shedding) is the complete proteolysis of all corneodesmosomes.
Among the corneodesmosomal proteins, desmoglein I, a member
of the cadherin adhesion molecules family, is believed to be a
major player, even though its degradation remains di⁄cult to
identify (Rawlings et al, 1995). Other corneodesmosomal compo-
nents like desmocollins (King et al, 1993), desmoplakins (Bernard
et al, unpublished results), and corneodesmosin (Serre et al, 1991)
are progressively degraded during desquamation (Lundstr˛m
et al, 1994). Corneodesmosin has recently been demonstrated
to be the preferred substrate of two SC serine proteases (Simon
et al, 2001).
Walsh and Chapman (1991) described desquamation as a
sequential action of glycosidases and proteases on corneodesmo-
somes. They demonstrated that (i) the addition of exogenous
proteases induced no major changes in corneodesmosome struc-
ture and composition, (ii) the addition of exogenous glycosidases
alone, or added after proteases treatment, caused only a mild
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fragmentation of the adhesive structures, and (iii) only glycosi-
dase treatment and the subsequent addition of exogenous pro-
teases caused dramatic degradation of the corneodesmosomal
structures. These ¢ndings indicate that sugar moieties are present,
protecting the corneodesmosomal protein structures from pro-
teolysis.Walsh and Chapman further demonstrated that endogly-
cosidases were more e¡ective than exoglycosidases. We recently
succeeded in ¢nding evidence for the ¢rst time of the existence
of endoglycosidase activity in the human SC (Bernard et al, 2001).
Based on zymographic analysis, several laboratories have
described the presence of proteases in the intercellular regions of
the SC: (i) a chymotrypsin-like protease named stratum corneum
chymotryptic enzyme (Egelrud and Lundstr˛m, 1991); (ii) a tryp-
sin-like protease named stratum corneum tryptic enzyme (Egel-
rud and Lundstr˛m, 1990; Suzuki et al, 1994; Ekholm et al, 2000);
(iii) a protease of the cysteine protease family named stratum
corneum thiol protease (SCTP) (Watkinson, 1999); and (iv) the
aspartic protease cathepsin D (Horikoshi et al, 1998; 1999).
The purpose of this study was to investigate if proteases other
than the above are present in human SC and might be a part of
the desquamation puzzle.
MATERIALS AND METHODS
Materials Pre-made sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) homogeneous or gradient gels, RainbowTM
molecular weight markers, a silver staining kit, a gel ¢ltration G75 HR10/30
column, a MonoS HR5/5 column, and a chromatography molecular
weight standard protein kit were from Amersham Pharmacia Biotech
(Uppsala, Sweden). Taq polymerase and second antibody antirabbit
coupled to peroxidase were from Sigma (St. Louis, MO). The RNA
preparation kit RNeasy was obtained from Qiagen (Hilden, Germany).
Oligonucleotides were synthesized by Genset (Evry, France). Enzchek
protease assay kit ‘‘green £uorescence’’ and Z-(Phe-Arg)2R110 (ZPA)
substrate were from Molecular Probes (Eugene, OR). Mouse monoclonal
antibody G36.19 against corneodesmosin was a gift from G. Serre
(Toulouse, France). Sheep antihuman cathepsin L antibody cat. no. 1911-
0507 was from Biogenesis (Poole, U.K.), human cathepsin L cat. no.
194973 from ICN (Orsay, France), and antirabbit biotinylated secondary
antibody from Roche Diagnostics (Meylan, France). VivaspinTM and
Sartocon microTM ultra¢ltration ¢lters were from Sartorius (G˛ttingen,
Germany). GelstarTM was from BMA (Rockland, ME).
Extraction of SC proteases SC proteins were collected by the so-called
scraping method. The scraping was carried out on the anterior surface of
the leg. Before scraping, the area was washed with 200 ml of a bu¡er
composed of 50 mM sodium phosphate bu¡er, pH 7, 5 mM
ethylenediamine tetraacetic acid (EDTA), 150 mM NaCl, and 0.1% Tween 20.
Thereafter, the washed area was scraped with the edge of a microscope slide
and continuously rinsed with the above bu¡er. The bu¡er containing the
corneocytes was collected in a container placed underneath the leg and
passed ¢rst over a Whatman No. 4 paper, thereafter over a Millipore 0.45
mm ¢lter, and ¢nally over a Millipore 0.22 mm ¢lter. The resulting SC
extract was concentrated to 6 ml by tangential ultra¢ltration on a
Sartocon microTM ultra ¢lter with a cut-o¡ of 10 kDa at 41C, applying a
counter pressure of 1 bar and a ¢ltrate exit £ow rate of 2 ml per min using
the K.BL apparatus (Sartorius). Protein content was evaluated with the
Bio-Rad protein assay, using bovine serum albumin as a standard. The
average protein concentration of the extract was about 0.5 mg per ml, i.e.,
a total of 3 mg per volunteer. Each experiment was performed with a
pooled extract from at least three volunteers. Informed consent was
obtained from all participants and the non-evasive sampling technique
didn’t require the approval of an ethical committee.
Gel ¢ltration Puri¢cation was performed at 41C on a BiologicTM
chromatography station (Bio-Rad, Marnes la Coquette, France). 250 ml of
the extract were directly loaded on a G75 HR10/30 column, previously
equilibrated with the extraction bu¡er (£ow rate of 0.5 ml per min),
where Tween 20 was substituted with the low-ultraviolet-absorbing form
of Triton X100 (bu¡er GF). Protein elution was monitored by recording
the OD280nm and 150 ml fractions were collected, 14 min after injection of
the sample, into 96-well plates ready for the analyses of enzymatic
activities or electrophoretic analysis. The apparent molecular weights were
calculated with the calibration curve obtained after injection of a mixture
of standard proteins from the low molecular weight protein kit
(Amersham Pharmacia Biotech).
Protease assays and zymograms To detect the caseinolytic activities,
we used the Enzchek kit from Molecular Probes, applying the procedure
proposed by the manufacturer, maintaining a 10 ml/200 ml sample to
substrate bu¡er ratio. Incubations were performed at 371C for 18 h. pH
studies were performed with the following bu¡ers: bu¡er A (acetate
bu¡er 0.1 M, pH 4.0^5.75) or bu¡er B (phosphate bu¡er 0.1 M, pH
5.75^8.25) complemented with 5 mM EDTA and 0.1% Triton X100
each.
Protease activities in the ¢rst 48 fractions obtained after gel ¢ltration
were measured with bu¡ers A and B at pH intervals of 0.25. In parallel
the same experiment was performed using the bu¡er containing 5 mM
cysteine. To exclude a possible bu¡er e¡ect on the £uorescence detection,
a standard curve with the £uorescent reaction product Bodipy-FL (BPFL)
was run with each bu¡er. Activities are expressed in fmoles released BPFL
per min per ml sample. Detection of £uorescence was performed on a
BioluminTM £uorescent plate reader from Bio-Rad (exc. 485 nm/em. 535
nm). Cathepsin-L-like protease activities were detected using the substrate
ZPA previously described by Assfalg-Machleidt et al (1992) at a ¢nal
substrate concentration of 10 mM after a 3 h incubation time with a 10 ml/
200 ml sample to substrate bu¡er ratio. The inhibition pro¢les of the
caseinolytic activities, detected at pH 5.5, were studied using the
following inhibitors: 1.4 mM E64, 1 mM leupeptine, 2.5 mM chymostatine,
1 mM CA074, 1 mM pepstatine, and 6 mM aprotinine.
The gelatin zymography was performed as described by Watkinson
(1999), except that the acrylamide concentration used was 12.5% instead
of 11%.
Cathepsin-L-like zymography was developed in our laboratory. After
horizontal SDS-PAGE separation on prefabricated gelbond PAG ¢lm-
supported gel (12.5% acrylamide homogeneous gels or gradient G8-18
gels) of the samples diluted 1 : 2 in Laemmli bu¡er without dithiothreitol
(DTT), a re-naturation step for 30 min at room temperature in bu¡er A
containing 2.5% Triton X100 was introduced. Thereafter the gel was
soaked for 1 min in bu¡er A with 5 mM cysteine and 10 mM ZPA.
Detection of the £uorescence was performed on a FluorimagerTM laser
scanner (Amersham Pharmacia Biotech).
Corneodesmosin degradation Fraction no. 40, obtained after gel
¢ltration chromatography and exhibiting the highest caseinolytic
cysteine-dependent activity, was dialyzed against 0.1 M acetate bu¡er, pH 5.
The dialyzed fraction (100 ml), adjusted to 5 mM cysteine, was added to 1mg
dry weight of acetonic SC powder prepared as previously described
(MeŁ hul et al, 2000). Two more assays were run in parallel, one with 1 mM
leupeptine and another with 1.4 mM E64. The control did not contain
proteases. After 24 h at 371C, the acetonic powder was centrifuged at
10,000 g for 10 min and the resulting pellet was extracted with 100 ml of
boiling Laemmli bu¡er containing 200 mM DTT. After centrifugation
(10,000 g for 10 min), the supernatant was recovered and assayed for
protein content using the Bio-Rad protein assay. Proteins were adjusted
to 1 mg per ml beforeWestern blot analysis. Mouse monoclonal antibody
G36.19, directed against corneodesmosin (Serre et al, 1991; Simon et al, 1997)
was used after 1 : 12,500 dilution in 25 mM TrisHCl, pH 7.2, 150 mM
NaCl, 0.05% (vol/vol) Tween 20 containing 0.5% nonfat milk (TBSTL).
Corneodesmosin degradation was assessed by quanti¢cation of the
43 kDa, 33 kDa, and 19 kDa SC degradation products of the native
cytosolic 52 kDa protein.
Preparation of extracts for Western blotting Reconstructed human
epidermis after 13 d of culture or SC or plantar SC obtained from human
volunteers was homogenized in Tris bu¡ered saline (TBS), pH 7.2,
containing 0.5% (vol/vol) Triton X100 on an ice bed (50 ml bu¡er per 1
mg tissue weight) with a polytron for 1 min before centrifugation
(10,000 g for 10 min). The protein contents of the respective supernatants
were quanti¢ed using the Bio-Rad protein assay. Samples were adjusted to
a protein concentration of 0.5 mg per ml before performing the protease
assays orWestern blot analysis.
Reconstructed human epidermis Reconstruction of human
epidermis with normal human keratinocytes was performed as described
previously (Tinois et al, 1991). The reconstructed epidermis was examined
at di¡erent time intervals during its reconstruction (days 1^13).
Western blotting The proteins were submitted to SDS-PAGE on
prefabricated gelbond PAG ¢lm-supported gels (12.5% acrylamide). The
molecular weight standard used was a 1 : 1 mix of low and high
molecular weight prestained RainbowTM standards from Amersham
Pharmacia Biotech. Proteins were transferred to a PVDF membrane
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(Immobilon P, Millipore, Saint Quentin en Yvelines, France) in the
presence of 20 mM TrisHCl, pH 8.3, 192 mM glycine, 0.1% (wt/vol)
SDS, and 20% (vol/vol) methanol using a trans-blot cell (Bio-Rad) with
a constant voltage of 60 V for 4 h. The ¢lters were blocked withTBSTL at
room temperature for 1 h. Thereafter, the ¢lters were incubated overnight
at 41C with the primary antibody. The ¢lters were then washed twice for 5
min inTBSTL and incubated at room temperature for 2 h with the second
antibody coupled to peroxidase, diluted inTBSTL.The ¢lters were washed
twice for 5 min in TBS before the detection procedure. The bands were
visualized using the ECLþ substrate system (Amersham Pharmacia
Biotech) on a FluorSmaxTM imager (Bio-Rad). Pre-stained RainbowTM
molecular weight markers served as standards and molecular weights
were calculated using Quantity-OneTM software (Bio-Rad).
Immunoprecipitation SC protein extract (500 ml) was incubated
overnight at 41C with 10 ml of a sheep antihuman cathepsin L antibody
(2.6 mg per ml). The resulting immunocomplex was precipitated using
protein G (protein G kit from Roche Molecular). After centrifugation of
the protein G agarose beads, 250 ml of the supernatant was applied to the
gel ¢ltration column. A control without antibody was run in parallel. The
functionality of the immunoprecipitation procedure was checked by
incubating 0.25 mg of puri¢ed human cathepsin L with 500 ml extraction
bu¡er following the same protocol as for the SC protein extract. Cysteine
protease caseinolytic activity was detected as described above.
Puri¢cation and identi¢cation of the SCTP The puri¢cation steps
were performed at 41C on a BiologicTM chromatography station (Bio-
Rad). SC soluble proteins from three healthy donors were obtained as
described above (9 mg protein in 18 ml bu¡er). The bu¡er was exchanged
with econo-PacTM 10DG columns (Bio-Rad) in cation exchange bu¡er: 50
mM acetate bu¡er pH 5.0, 350 mM NaCl, 1 mM EDTA, 0.1% reduced
Triton X100 (bu¡er A). The resulting protein extract (9 mg protein in
24 ml bu¡er) was loaded on a Mono STM HR5/5 column (Amersham
Pharmacia Biotech) equilibrated with the same bu¡er at a £ow rate of
1 ml per min. The column was washed with ¢ve column volumes of
bu¡er A. Elution was performed using bu¡er A containing 550 mM
NaCl. Proteins were eluted with a linear NaCl gradient ranging from
0 to 100% in 40 column volumes. The £ow rate was 1 ml per min.
Fractions (0.42 ml) were collected starting at the beginning of the
gradient. Protein elution was monitored by recording the OD280nm.
After gel chromatography, the eluted proteins were submitted to SDS-
PAGE on prefabricated gelbond PAG ¢lm-supported gels (G8-18) using a
1 : 2 dilution with 2 Laemmli sample bu¡er without DTT and silver
stained with the silver nitrate kit (Amersham Pharmacia Biotech). SCTP
activity was revealed using the gelatin and the ZPA zymography
Figure1. Caseinolytic activities of SC proteases separated by gel ¢ltration.The caseinolytic activities were detected with the Enzchek kit (Molecular
Probes) used at pH ranging from 4 to 8.25 on fractions after gel ¢ltration of 125 mg protein extracted from human SC.Very low activities were detectable at
basic pH (a, arrow 1 on two-dimensional view). The highest activities were detectable at acid pH split into three groups (a): group Awith an 8090 kDa
molecular weight and pH optimum at 5.5; group B with a 40 kDa molecular weight and pH optimum between 5.25 and 5.5; group C with a 25 kDa
molecular weight and pH optimum between 5.25 and 5.5. After addition of cysteine, a new caseinolytic group D was revealed with a molecular weight
of 28 kD and pH optimum of 55.5 (b). Compared to the results without cysteine, group C is masked by this new group. Group A and B proteases are still
visible. Data obtained without cysteine (a) were subtracted from the data obtained with cysteine (b). This di¡erential analysis shows the group D activity (c).
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methods. SCTP of the most active fractions were pooled, precipitated (10%
trichloroacetic acid) and sequenced (Edmann sequencing) as previously
described (Bernard et al, 2001).
Human cathepsin L2 antibodies The anti-cathepsin L2 polyclonal
antibody was produced by CovalAb (Lyon, France) by immunizing
rabbits with selected peptides from the cathepsin L2 sequence.
One peptide was retained as potentially immunizing: DBcat15CE
(CFRNQKFRKGKVFRE amino acid residues 94^108 from Swissprot
sequence 060911). The rabbit were immunized with a proprietary protocol
(CovalAb) and the resulting antibodies were a⁄nity puri¢ed using a
peptide immobilized column. Antibody concentration obtained after the
immuno-puri¢cation step was 0.5 mg per ml. For Western blot analysis,
the DBcat15CE antibody was diluted 1 : 1000.
Reverse transcription polymerase chain reaction (RT-PCR)
analysis Total RNA from reconstructed human epidermis was prepared
using an RNeasy kit. Brie£y, two samples of the reconstructed epidermis
(1 cm2 each) were homogenized in 300 ml of lysis bu¡er (included in the
kit) and the cell debris was removed using a QIA shredder column. cDNA
was produced from puri¢ed total RNA using the ¢rst-strand cDNA
synthesis kit. Expression analysis of cathepsin L2, loricrin, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was performed by
RT-PCR using equivalent amounts of total RNA (0.1 mg per assay), taq
polymerase, and di¡erent primers (for cathepsin L2, 50 -ctcacacatt-
ggggtagctggc-30 and 50 -cttcccaaatctgtggattg-30; for loricrin, 50 -accacgga-
ggcgaaggagtt-30 and 50 -ctggggttgggaggtagttg-30; for GAPDH, 50 -aatcc-
catcaccatcttcca-30 and 50 -gtcatcatatttggcaggtt-30) under the following
conditions: 1 cycle for 2 min at 951C, 25^30 cycles (941C for 30 s, 551C
for 30 s, 721C for 30 s), and 1 cycle at 721C for 2 min in parallel. The
resulting PCR products were visualized by GelstarTM staining after
separation on 2%^3% (wt/vol) agarose gels.
Histochemistry Thin cryosections (5 mm) of skin from plastic surgery
were obtained with a Microm HM500M microtome. Sections were ¢xed
in acetone at 201C for 5 min and air dried. Immunohistochemical
detection of cathepsin L2 was performed with streptABComplex/HRP
kit from Dako and AEC detection kit from Sigma according to the
manufacturer’s instructions except that the incubation steps were extended
to 1 h using DB15CE diluted 1 : 2 in phosphate-bu¡ered saline/Tween 20
0.05% (PBST) as primary antibody and an antirabbit biotinylated
secondary antibody from Roche Molecular diluted 1 : 200 in PBST.
Nuclei were counterstained with hematoxylin.
RESULTS AND DISCUSSION
Caseinolytic activity of an SC extract Gel ¢ltration of the
SC protein extract resulted in the separation of two distinct
caseinolytic activities, one around pH 8.0 and the large majority
at pH 5^5.5 (Fig 1a^c), a pH characteristic for the surface of the
Figure1. Continued.
Figure 2. SC caseinolytic protease pro¢les obtained at pH 5.5 and
the e¡ect of speci¢c inhibitors. Group A proteases were essentially af-
fected by 1 mM pepstatin (3). Group B proteases were totally inhibited by 1
mM pepstatin (3) and partially inhibited by 6 mM aprotinin (1). Group C
was strongly inactivated by 6 mM aprotinin (1) and to a lesser extent by
2.5 mM chymostatin (2).
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SC (Shman and Vahlquist, 1994). As proteases involved in the
desquamation process are likely to have an acidic pH optimum,
we decided to further characterize the acidic activity. Based
on the calculated molecular weight, the responsiveness to class
speci¢c inhibitors, and the zymograph pro¢le, we distinguished
four distinct groups within the acidic active part of the extract.
Group A, with a calculated average molecular weight of
80 kDa (Fig 1a), and completely inhibited by the classic aspartic
protease inhibitor pepstatin (Fig 2.3), was considered to comprise
part of the cathepsin-E-like family. Even though, to our
knowledge, this type of protease activity has not yet been
described in the SC, we did not perform any further
characterization, as its caseinolytic activity was very low.
Group B, characterized by an average molecular weight of 40
kDa (Fig 1a), a total inhibition by pepstatin (Fig 2.3), and a broad
pH optimum, was supposed to represent the cathepsin D activity.
The very high caseinolytic activity in our SC extract was not
surprising, as Horikoshi et al (1998; 1999) described cathepsin D
as the major SC proteolytic activity, possibly implicated in
desquamation.
Group C, exhibiting a molecular weight of 24 kDa (Fig 1a),
with a sensitivity to chymostatin and aprotinin (Figs 2.1, 2.2),
comprised the chymotrypsin-like activity. As it perfectly
converted (data not shown) the synthetic substrate S2586
(Egelrud, 1993), we assumed that this group represents mainly
the acidic activity of the chymotryptic enzyme (SCCE),
described by Hansson et al (1994).
Group D attracted our particular interest for various reasons. It
represented the main caseinolytic activity in the SC extract
studied. It revealed its activity only in the presence of cysteine
(Fig 1b, c), required the presence of mild reducing agents, and
exhibited a distinct inhibitory response to speci¢c inhibitors.
Almost insensitive to pepstatin (1 mM) and aprotinin (6 mM)
(Figs 3.5, 3.4), the activity was completely inhibited by E64
(1.4 mM) (Fig 3.1) and not a¡ected by the speci¢c cathepsin
B inhibitor CA074 (1 mM) described by Inubushi et al (1994)
(Fig 3.6). This particular inhibition pro¢le excluded the presence
of cathepsin B, and its sensitivity to leupeptin (1 mM) and
chymostatin (2.5 mM) (Figs 3.2, 3.3) ruled out a cathepsin-H-like
activity (Schwartz and Barett, 1980). So far, all of the above data
suggested the presence of a cathepsin-L-like protease of the
papa|« n-type family. The fact that cathepsin-L-speci¢c antibodies
failed to immunoprecipitate the proteolytic activity in group D,
however, clearly indicated that this activity cannot be attributed
to cathepsin L itself but is exerted by another member of this
family (data not shown).
Figure 3. SC caseinolytic cysteine-dependent (group D) protease pro¢les at pH 5.5 and e¡ect of speci¢c inhibitors.The curves presented were
obtained by subtracting the activities obtained with and without cysteine. Group D protease activity was tested in the presence of (1) 1.4 mM E64, (2) 1 mM
leupeptin, (3) 2.5 mM chymostatin, (4) 6 mM aprotinin, (5) 1 mM pepstatin, (6) 1 mM CA074.
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We therefore ¢rst checked whether the recently described
SCTP (Watkinson, 1999), another member of the cathepsin L
family, is involved. Superimposing the caseinolytic and
gelatinolytic activity, detected in the fractions of the SC extract,
showed that SCTPactivity did not match group D activity (Fig 4).
At this stage of investigation, we decided to name the protease
present in group D, stratum corneum cathepsin-L-like protease
(SCCL). Due to the uniform response to speci¢c inhibitors we
were convinced that we were dealing with a single protease.
To evaluate whether this new protease is implicated in the
degradation of corneodesmosomes, we assayed corneodesmosin
degradation by SCCL. Exposing corneocytes to puri¢ed SCCL
followed by a Western blot immunodetection of the
characteristic 33 kDa corneodesmosin fragment (Simon et al,
2001) revealed an e⁄cient degradation of corneodesmosin (Fig 5).
As expected from the inhibition pro¢le (see Fig 3), leupeptin
reduced, and E64 completely inhibited, SCCL-dependent
degradation of corneodesmosin. Interestingly the amount
of intact corneodesmosin increased in the presence of E64,
indicating that this inhibitor probably blocks other cysteine
proteases present in this extract. This observation can be
explained by E64 inhibition of endogenous cysteine proteases
associated with the corneocytes.
Attempts to purify SCCL protease for further characterization
by gel ¢ltration, cation exchange, and hydrophobic interaction
chromatography enabled us to dramatically increase its speci¢c
activity but did not provide su⁄cient material to sequence the
protein. E¡orts are in progress to obtain su⁄cient material to
sequence SCCL, a protease particularly interesting because of its
surprising high speci¢c activity.
Figure 4. Comparison of SCTP (gelatinase) and group D cysteine-
dependent protease activity after gel ¢ltration chromatography. Hu-
man SC extract separated by gel ¢ltration chromatography was analyzed
for its cysteine-dependent activity. The activity detected on the gelatin zy-
mogram (SCTP) did not correlate with the caseinolytic dependent activity
(group D).
Figure 5. Western blot analysis of corneodesmosins (antibody
G36.19) extracted from human SC after exposure to semi-puri¢ed
group D protease at pH 5 plus 5 mM cysteine. Control, SC incubated
without addition of protease;þD, with protease and without in-
hibitor;þDþL, with protease and with leupeptin 1 mM;þDþE64, with
protease and with E64 1.4 mM.The major SC forms of corneodesmosin are
also indicated by their molecular weight (kDa).
Figure 6. Puri¢cation of SCTP by cation exchange chromatogra-
phy. 5 mg of protein extracted from human SC were loaded on a cation
exchange chromatography column at pH 5. Proteins were eluted with a
gradient ranging from 350 to 550 mM NaCl in 40 column volumes. Frac-
tions (0.42 ml) were collected in a 96-well plate. Fractions 7 to 54 were
analyzed for SCTP activity by gelatin zymography (GZ) and ZPA zymo-
graphy (ZPAZ). Proteins of these fractions were separated by SDS-PAGE
(Eph) on a G8-18 gradient and silver stained. Arrows indicate the molecular
weights calculated for the detected activities and the molecular weight
markers for the SDS-PAGE gel.
Figure 7. Coupling zymography and protein staining for the iden-
ti¢cation of puri¢ed SCTP. Fractions 3237 from the cation exchange
step supporting SCTP activity (Fig 6) were pooled and concentrated to
250 ml. (S), untreated sample; (TCA), trichloroacetic acid precipitated sam-
ple. The same gel was used in (1) to detect its cathepsin-L-like activity per-
forming a ZPA zymogram (ZPAZ) and (2) Coomassie blue stained to
reveal the band supporting the enzyme activity (indicated by double-headed
arrows) Arrows on the right indicate the molecular weights of the protein
associated with the activity (35 kDa) and of two other stained proteins.
The 35 kDa (SCTP) band was then cut and sequenced.
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During our detailed analysis of the various protease activities,
we performed experiments to make sure that SCCL activity
is distinct from SCTP activity. The gelatin zymograms and
caseinolytic pro¢les always identi¢ed SCTP and SCCL activity
in distinct but neighboring fractions (data not shown). To
provide unequivocal evidence that what we called SCCL is
distinct from SCTP, the gelatinolytic activity was puri¢ed. We
succeeded in a one-step identi¢cation by cation exchange
chromatography (Fig 6). The most active fractions detected by
gelatin zymogram and ZPA zymogram, i.e., fractions 32^37,
were pooled and concentrated to perform another ZPA
zymogram with the objective of obtaining su⁄cient material for
sequencing. Figure 7 clearly shows that SCTP-related activity is
associated with the 35 kDa protein. The band was cut, trypsin
digested, and submitted to Edmann sequencing. To our surprise,
the resulting peptide sequence revealed a 100% homology with
the recently described cathepsin L2, also named cathepsin U or
V protease (Adachi et al, 1998; Santamaria et al, 1998; Itoh et al,
1999; Kinoshita et al, 2001). These results indicate that SCTP and
cathepsin L2 are two distinct names for the same enzyme.
Cathepsin L2 is expressed in colorectal and breast cancer cell
lines as well as in tumors of diverse origins, including ovarian
and renal carcinomas (Santamaria et al, 1998), and in testis,
thymus, and cornea (Itoh et al, 1999; Kinoshita et al, 2001).
A detailed analysis of the cathepsin L2 sequence together with
the results obtained in Western blots using a speci¢c antibody
revealed some discrepancy with earlier reports concerning the
processing of cathepsin L2 and the putative active form of the
enzyme. Adachi et al (1998) reported that the full-length cDNA
encodes a peptide of 334 amino acids with a potential peptide
signal (aa 1^17) and a putative activation peptide (aa 18^113) plus
two potential N-glycosylation sites. Br˛mme et al (1999)
described a recombinant heterogeneous pro-form of 38 and
45 kDa and an autocatalytic processing, resulting in a 31 and a
35 kDa mature form. Even though the latter result con¢rms
the activation site predicted by Adachi, our results clearly
demonstrate a distinct processing in the epidermis: (i) sequence
analysis of the puri¢ed catalytic active form of cathepsin L2
comprised the aa sequence 30^33 and 39^49 (see Table I)
and (ii) an antibody recognizing the cathepsin L2 aa sequence
94^108 decorated both the pro-form and the active form of the
enzyme. Furthermore, this polyclonal antibody decorated
cathepsin L2 in Western blots and did not cross-react with
puri¢ed cathepsin L (data not shown). This antibody was used
to further characterize the epidermal forms of cathepsin L2.
Western blot analysis A comparative Western blot analysis of
cathepsin L2 expression in SC extracts obtained from plantar SC
and nonpalmoplantar SC (Fig 8) con¢rmed the presence of the
39 kDa pro-form and the mature 34 and 35 kDa forms in
nonpalmoplantar SC. In addition, a 33 kDa band, probably a
further degradation product, was detected. The plantar SC only
contained the 39 kDa inactive pro-form of the enzyme. This is
the reason whyWatkinson, who analyzed plantar SC only for its
catalytic gelatinolytic enzyme activity, could not detect the
presence of this enzyme and concluded that it was not expressed
in plantar SC.
A more detailedWestern blot analysis combined with a gelatin
zymogram of the fractions obtained after gel ¢ltration of the SC
Table I. Amino acid sequences obtained by Edmann sequencing of the puri¢ed SCTP and sequence chosen
for the generation of antibody
Amino acid sequence
aa position extracted
in SwissProt sequence for
hCatL2 (accession 060911)
aa correspondence in
alignement with hcatL sequence.
(SwissProt accession P07711)
Edman sequence nn1 XYQWK 30^33 TKWK
Edman sequence nn2 LYGANEEGWRR 39^49 LYGMNEEGWRR
Edman sequence nn3 FSATGALEGQMFRK 141^154 FSATGALEGQMFRK
Edman sequence nn4 NLDHGVLVVGYGFEGANSNNSK 274^295 DMDHGVLVVGYGFESTESDNNK
Peptide used for rabbit immunisation CFRNQKFRKGKVFRE 94^108 GFQNRKPRKGKVFQE
nSequences obtained by Edmann sequencing of peptides released by trypsinolysis of a 35 kDa band supporting SCTP activity. These sequences have 100% homology
with the sequence published for cathepsin L2. The sequence used to produce the anti-peptide antibody is given. Highlighting in bold and underlined letters depict the
di¡erences between the sequences obtained and the corresponding sequences in human cathepsin L. X is an unidenti¢ed residue.
Figure 8. Western blot analysis using the polyclonal anti-cathepsin
L2 antibody DBcat15CE. Plantar SC and SC protein extracts (3.7 mg
per each lane) were run on a 12.5% acrylamide SDS gel. After transfer to
a PVDF membrane, immunoreactive proteins were detected with the ECL
method. Arrows on the right indicate the calculated molecular weights. Ar-
rows on the left indicate the position of two molecular weight markers.
Figure 9. Comparative analysis by Western blot with DBcat15CE
antibody and gelatin zymography of SC fractions obtained by gel
¢ltration. (WB),Western blot revealing the 39 kDa inactive form of cathe-
psin L2 and its 35 kDa active form; (GZ), gelatin zymography revealing the
35 kDa protein supporting cathepsin L2 activity (identical with the 35 kDa
in theWestern blot). Arrows on the right indicate the calculated molecular
weights of the detected bands.
Figure10. RT-PCR analysis of cathepsin L2 expression during the
reconstruction of human epidermis.The ¢gure shows the band inten-
sity of speci¢c amplicons generated by a set of primers corresponding to a
di¡erentiation marker (loricrin) and a housekeeping gene (GAPDH) com-
pared with cathepsin L2 (CatL2) (see Materials and Methods).
598 BERNARD ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
extract revealed the presence of two bands (Fig 9), one with a
calculated molecular weight of 39 kDa and devoid of catalytic
activity in fractions 25^30, and the second with a molecular
weight of 35 kDa and catalytic activity evidenced in fractions
29^39. These results clearly show that our antibody recognizes
the 39 kDa pro-form as well as the 35 kDa active form of
epidermal cathepsin L2. An additional set of experiments was
performed to characterize the pattern of cathepsin L2 expression
in human epidermis.
Cathepsin L2 expression and epidermal di¡erentiation The
reconstructed human epidermis model was used to analyze
cathepsin L2 expression during keratinocyte di¡erentiation. RT-
PCR analysis was performed at di¡erent time intervals during
the reconstruction of the epidermis, days 113 (Fig 10). The
time course clearly evidenced that cathepsin L2 expression is
independent of keratinocyte di¡erentiation. Experiments to
identify at which level of the strati¢ed epidermis the pro-form of
cathepsin L2 becomes activated are in progress. Immuno-
localization of cathepsin L2 in normal human skin with the
DB15CE antibody con¢rms the presence of cathepsin L2
throughout the living layers of the epidermis (Fig 11). The
reduced staining at the intermediate layers remains to be
explained. The negative staining of the SC for the enzyme is less
surprising, as it is known that immunostaining in this part of the
epidermis is often hampered by the strong hydrophobic
environment.
In conclusion, the analysis of the SC extract from human skin
revealed the presence of a new cysteine protease, which we
named SCCL, exhibiting a surprisingly high speci¢c activity.
Moreover, the puri¢cation, sequencing, and detailed analysis at
the molecular level of another cysteine protease present in the
SC extract demonstrated that what was described earlier to be
the ‘‘stratum corneum thiol protease’’ (SCTP) is not a distinct
epidermal enzyme but identical with cathepsin L2. A view of
these latest results in relation to other existing data concerning
proteases involved in the desquamation process is presented
in Table II. The fact that SCCL degrades corneodesmosin,
a key component of the corneodesmosomes, indicates a possible
active function of this enzyme in the desquamation process.
Its puri¢cation and further characterization are in progress.
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